Ardsley Advisory Partners’s Aceragen Inc ACGN Stock Holding History

Ardsley Advisory Partners’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-736	Closed	-$211K	–	181
2017 Q4	$211K	Buy	+736	New	+$210K	0.03%	125

Other funds holding ACGN

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Ardsley Advisory Partners's ACGN Position: Q1 2018 in Review

Ardsley Advisory Partners sold out of Aceragen Inc (ACGN) in Q1 2018, closing a stake of 736 shares — an estimated $211K sold.

Ardsley Advisory Partners first reported a position in ACGN in Q4 2017 and held it in 1 quarter. The position peaked at $211K in Q4 2017. 107 funds tracked by Wall St. Rank hold ACGN as of Q1 2018.

Ardsley Advisory Partners reported no remaining Aceragen Inc position as of Q1 2018 after selling out during the quarter.
Ardsley Advisory Partners sold 736 Aceragen Inc shares in Q1 2018, an estimated $211K.
Ardsley Advisory Partners first reported a position in Aceragen Inc in Q4 2017 and held it in 1 quarter.
Ardsley Advisory Partners's Aceragen Inc position peaked at $211K in Q4 2017.
107 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2018.

Based on Ardsley Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.